This content is machine translated Relapsing-remitting multiple sclerosis (RRMS) New S1P1 modulator expands the therapeutic spectrum The selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod has been approved in Switzerland since November 2021 for the treatment of relapsing-remitting multiple sclerosis (RRMS) with active disease. The approval is…
View Post 4 min This content is machine translated Ischemic stroke “Time is brain” – guideline recommendations for acute therapy. Worldwide, strokes are among the leading causes of mortality and morbidity. In a new edition of the S2e guideline on acute therapy of ischemic insults, recommendations are given on the…
View Post 3 min This content is machine translated Multiple sclerosis Improving quality of life as a goal of effective treatment Effective treatment of multiple sclerosis goes well beyond just MRI findings or blood work. Physical and mental well-being is at least as important for those affected. Therefore, more and more therapies…
View Post 3 min This content is machine translated Casein Milk may increase MS symptoms People with multiple sclerosis often complain of more severe disease symptoms after consuming dairy products. A protein in cow’s milk can trigger inflammation that targets the “insulating layer” around nerve…
View Post 2 min This content is machine translated Parkinson's disease Tracking the variability of phenotypes Whereas earlier disease concepts assumed that patients with PD would follow a rather uniform clinical course within their disease entities (PD, PSP, CBD, MSA), more recent cohort data show that…
View Post 10 min This content is machine translated Dementia Clarification in practice Questions about brain performance due to subjective complaints or environment-reported cognition problems are increasingly common in primary care consultations. This is due to demographic developments. Dementias increase with age: 75-… CME-Test
View Post 5 min This content is machine translated Migraine prophylaxis using antibody therapy Patients with frequent migraine attacks in particular benefit Migraine is the most common severe headache that prompts patients to see a primary care physician. The suffering of those affected is often considerable. For several years, a new group…
View Post 2 min This content is machine translated Update S1 Guideline Headache associated with overuse of analgesics or migraine medications Under the direction of Hans-Christoph Diener, Department of Neuroepidemiology, Institute of Medical Informatics, Biometry and Epidemiology (IMIBE), University of Duisburg-Essen, and Prof. Dr. Peter Kropp, Director of the Institute of…
View Post 4 min This content is machine translated Alzheimer Amyloid and tau are a dangerous pair In the course of Alzheimer’s disease, the proteins “amyloid” and “tau” accumulate in the brain. A DZNE study with more than 200 participants now provides insights into the interplay of…
View Post 4 min This content is machine translated SARS-CoV2 Changes in brain structure over the long-term in non-hospitalized subjects. Using data from the longitudinal “UK Biobank” initiated in the pre-pandemic era, cerebral MRI findings before and after COVID-19 were collected for the first time in the same individuals and…
View Post 5 min This content is machine translated Long Covid With holistic treatment and patience back to normal everyday life Even after a mild covid infection, prolonged symptoms can occur that significantly limit those affected. There are an increasing number of clinical facilities that offer specialized consultations and programs. The…
